Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Lapatinib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Neoplasm Metastasis 3 Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Patient Compliance 1 Ovarian Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 6 Etoposide 4 Prednisone 3 Doxorubicin 3 romidepsin 2 pembrolizumab 2 etoposide phosphate 2 Vincristine 2 Melphalan 2 Brentuximab Vedotin 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 sodium-iodide symporter 1 ruxolitinib 1 prednylidene 1 glofitamab 1 fludarabine phosphate 1 fludarabine 1 duvelisib 1 deltacortene 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Specimen Handling 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡